These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15123371)

  • 1. Hepatitis C virus and liver steatosis: when fat is not beautiful.
    Negro F
    J Hepatol; 2004 Mar; 40(3):533-5. PubMed ID: 15123371
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-beta-lipoproteinemia.
    Colloredo G; Sonzogni A; Rubbia-Brandt L; Negro F
    J Hepatol; 2004 Mar; 40(3):562-3. PubMed ID: 15123378
    [No Abstract]   [Full Text] [Related]  

  • 3. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
    Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
    J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-induced steatosis: an overview.
    Negro F
    Dig Dis; 2010; 28(1):294-9. PubMed ID: 20460926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.
    Fierbinţeanu-Braticevici C; Mohora M; Tribus L; Petrişor A; Creţoiu SM; Creţoiu D; Usvat R; Ioniţă L
    Rom J Morphol Embryol; 2010; 51(2):235-42. PubMed ID: 20495737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomechanism of metabolic disorders in HCV infection].
    Boroń-Kaczmarska A
    Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.
    Hissar SS; Goyal A; Kumar M; Pandey C; Suneetha PV; Sood A; Midha V; Sakhuja P; Malhotra V; Sarin SK
    J Med Virol; 2006 Apr; 78(4):452-8. PubMed ID: 16482560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Utili R; Ruggiero G
    Hepatology; 1999 Dec; 30(6):1530-1. PubMed ID: 10610353
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
    Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2006 Nov; 10(4):793-819. PubMed ID: 17164118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis in chronic hepatitis C: why does it really matter?
    Asselah T; Rubbia-Brandt L; Marcellin P; Negro F
    Gut; 2006 Jan; 55(1):123-30. PubMed ID: 16344578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatosis in chronic hepatitis C: friend or foe?
    Negro F
    Liver Int; 2008 Mar; 28(3):294-6. PubMed ID: 18290771
    [No Abstract]   [Full Text] [Related]  

  • 19. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
    Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
    J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.